A detailed history of New England Research & Management, Inc. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, New England Research & Management, Inc. holds 1,380 shares of IDXX stock, worth $568,918. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,380
Previous 1,280 7.81%
Holding current value
$568,918
Previous $624,000 11.7%
% of portfolio
0.33%
Previous 0.3%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$455.08 - $517.19 $45,508 - $51,719
100 Added 7.81%
1,380 $697,000
Q2 2024

Jul 09, 2024

SELL
$468.04 - $548.53 $35,103 - $41,139
-75 Reduced 5.54%
1,280 $624,000
Q1 2024

Apr 16, 2024

SELL
$515.08 - $576.87 $218,909 - $245,169
-425 Reduced 23.88%
1,355 $732,000
Q4 2023

Feb 06, 2024

BUY
$391.37 - $557.56 $119,367 - $170,055
305 Added 20.68%
1,780 $988,000
Q3 2023

Oct 10, 2023

BUY
$432.42 - $556.67 $637,819 - $821,088
1,475 New
1,475 $645,000
Q4 2022

Jan 09, 2023

SELL
$324.64 - $441.27 $462,612 - $628,809
-1,425 Reduced 57.0%
1,075 $439,000
Q3 2022

Oct 06, 2022

BUY
$325.8 - $407.78 $814,500 - $1.02 Million
2,500 New
2,500 $815,000
Q2 2022

Jul 20, 2022

SELL
$327.37 - $553.44 $188,237 - $318,228
-575 Closed
0 $0
Q1 2021

Apr 16, 2021

SELL
$465.18 - $551.79 $11,629 - $13,794
-25 Reduced 4.17%
575 $281,000
Q3 2020

Oct 08, 2020

SELL
$334.54 - $406.31 $150,543 - $182,839
-450 Reduced 42.86%
600 $236,000
Q1 2020

Jun 15, 2020

BUY
$182.94 - $290.97 $192,087 - $305,518
1,050 New
1,050 $254,000
Q1 2019

Apr 03, 2019

SELL
$178.02 - $225.69 $307,084 - $389,315
-1,725 Closed
0 $0
Q4 2018

Jan 11, 2019

BUY
$176.18 - $248.92 $303,910 - $429,387
1,725 New
1,725 $321,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.3B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.